3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Advanced Solid Tumours
5
Squamous Cell Carcinoma of Head and Neck
3
Solid Tumors
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Leukemia, Myeloid, Acute
2
Glioblastoma
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Muscle Invasive Bladder Cancer
1
Meningeal Carcinomatosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Carcinoma, Endometrioid
1
Brain Neoplasms
1
Blast Crisis
1
Astrocytoma
1
Advanced Solid Tumors
1
Adenocarcinoma Of Esophagus
1
Interventions
Cisplatin
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
pembrolizumab
4
Specimen Handling
4
Radiation
3
motexafin gadolinium
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Fluorouracil
2
Biopsy
2
zimberelimab
1
peposertib
1
olaparib
1
ipatasertib
1
dl1520
1
adavosertib
1
Surgical Procedures, Operative
1
Resistance Training
1
Protons
1
Proton Therapy
1
Platinum
1
Pemetrexed
1
Paclitaxel
1
Nutritional Status
1
NVP-BKM120
1
Laser Therapy
1
L 778,123
1
Immunohistochemistry
1
Hyperthermia, Induced
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Laryngeal Neoplasms
×
adavosertib
×
Clear all
NCT03028766
2024-09-19
WISTERIA
University of Birmingham
Phase 1
Completed
9 enrolled